Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aastrom puts mid stage trial of stem cells on hold after patient died for unknown reasons
Yahoo/AP
Friday, May 22, 2009 - 11:13am
tags:
Aastrom, drug trials
FDA, Clinical Trial Updates: Genzyme, Human Genome Sciences, Eli Lilly, NeurogesX
Seeking Alpha
Friday, May 22, 2009 - 11:12am
tags:
FDA, Eli Lilly, Genzyme, drug trials, Human Genome Sciences, NeurogesX
Gilead Sciences: Stock in Decline or Great Buying Opportunity?
Seeking Alpha
Friday, May 22, 2009 - 10:05am
tags:
Gilead Sciences
Vanda Holding Up Well
Seeking Alpha
Friday, May 22, 2009 - 10:04am
tags:
Vanda, Fanapt
Merck, CIGNA Prove It Pays to Be Healthy
Seeking Alpha
Friday, May 22, 2009 - 10:02am
tags:
Merck, Cigna, diabetes
If You Can't Beat 'Em, Join 'Em: Pharma Goes Generic
Motley Fool
Friday, May 22, 2009 - 7:29am
tags:
Big Pharma, generics, Teva Pharmaceuticals, Perrigo Company, Mylan, Watson Pharmaceuticals, Novartis, GSK, Pfizer, Sanofi
The AstraZeneca Dilemma
Motley Fool
Friday, May 22, 2009 - 7:28am
tags:
AstraZeneca, M&A, patents
Jury Still Out On Isis Cholesterol Drug
Forbes
Friday, May 22, 2009 - 7:26am
tags:
Isis Pharmaceuticals, cholesterol, mipomersen, Genzyme
Johnson & Johnson Seeks Cancer Medicines in Cougar Acquisition
Bloomberg
Friday, May 22, 2009 - 7:25am
tags:
JNJ, buyouts, Cougar Biotechnology
Antibiotic’s $1 Billion Success May Spur Cubist Acquisition
Bloomberg
Friday, May 22, 2009 - 7:24am
tags:
Cubist Pharmaceuticals, M&A, antibiotics, Cubicin
Glaxo may have $1.9 billion showdown with IRS: WSJ
Marketwatch
Thursday, May 21, 2009 - 6:34pm
tags:
IRS, taxes, GSK
Not So Fast, Schering ... er, Merck ... er, Whoever You Are
Motley Fool
Thursday, May 21, 2009 - 6:33pm
tags:
Merck, Schering Plough, JNJ, Remicade
GlaxoSmithKline shareholders back executive pay reforms
Guardian,UK
Thursday, May 21, 2009 - 3:24pm
tags:
GSK, Pharma CEOs
Stem Cell Stocks Mixed on Heavy Volume Action
Yahoo/Indie Research
Thursday, May 21, 2009 - 3:21pm
tags:
stem cells, Neuralstem, Cytori, Aastrom
Celator Pharmaceuticals says Cephalon will examine its technology
Yahoo/AP
Thursday, May 21, 2009 - 3:20pm
tags:
Celator, Cephalon
JNJ: Don't Get Fooled by Dividend Plays
Seeking Alpha
Thursday, May 21, 2009 - 3:19pm
tags:
JNJ, dividends
Drug stocks lose ground; Vical rallies on vaccine news
Marketwatch
Thursday, May 21, 2009 - 11:41am
tags:
Vical, drug stocks
[video]Mad About Options: Like a Bull in a Hospital (Biogen)
Yahoo/TheStreet.com
Thursday, May 21, 2009 - 11:39am
tags:
Biogen Idec, options
Human Genome Sciences files for approval of ABthrax, designed to treat inhaled anthrax
Yahoo/AP
Thursday, May 21, 2009 - 11:38am
tags:
Human Genome Sciences, anthrax, FDA, ABthrax
Eli Lilly starts late-stage Alzheimer's drug tests
Yahoo/AP
Thursday, May 21, 2009 - 10:50am
tags:
Eli Lilly, drug trials, Alzheimer's disease, solanezumab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.